Intravenous Prostaglandin E1 Treatment in Outpatients With Intermittent Claudication.

Trial Profile

Intravenous Prostaglandin E1 Treatment in Outpatients With Intermittent Claudication.

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2014

At a glance

  • Drugs Alprostadil (Primary) ; Pentoxifylline
  • Indications Embolism and thrombosis; Intermittent claudication; Peripheral arterial occlusive disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Schwarz Pharma AG; UCB
  • Most Recent Events

    • 26 May 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 26 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top